Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Hemoglobinopathy Drugs Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Hemoglobinopathy Drugs Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Hemoglobinopathy Drugs Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Hemoglobinopathy Drugs Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Novartis
  • AstraZeneca
  • Bluebird
  • Bristol-Myers Squibb
  • Emmaus Medical
  • Acceleron Pharma
  • HemaQuest Pharmaceuticals
  • Eli Lilly and Company
  • Celgene

By the Product Type, the market is primarily segmented into:

  • Hydroxyurea
  • Glutamine
  • Zynteglo
  • Other

By Applications, the market is segmented into:

  • Sickle Cell Diseases
  • Thalassemia

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Hemoglobinopathy Drugs Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Hemoglobinopathy Drugs Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Hemoglobinopathy Drugs Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Hemoglobinopathy Drugs Market

The Hemoglobinopathy Drugs Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Hemoglobinopathy Drugs Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hemoglobinopathy Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Hydroxyurea
1.4.3 Glutamine
1.4.4 Zynteglo
1.4.5 Other
1.5 Market by Application
1.5.1 Global Hemoglobinopathy Drugs Market Share by Application (2019-2025)
1.5.2 Sickle Cell Diseases
1.5.3 Thalassemia
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hemoglobinopathy Drugs Market Size
2.2 Hemoglobinopathy Drugs Growth Trends by Regions
2.2.1 Hemoglobinopathy Drugs Market Size by Regions (2019-2025)
2.2.2 Hemoglobinopathy Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis

3 Market Share by Key Players
3.1 Hemoglobinopathy Drugs Market Size by by Players
3.1.1 Global Hemoglobinopathy Drugs Revenue by by Players (2014-2019)
3.1.2 Global Hemoglobinopathy Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Hemoglobinopathy Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Hemoglobinopathy Drugs Key Players Head office and Area Served
3.3 Key Players Hemoglobinopathy Drugs Product/Solution/Service
3.4 Date of Enter into Hemoglobinopathy Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hemoglobinopathy Drugs Market Size by Type (2014-2019)
4.2 Global Hemoglobinopathy Drugs Market Size by Application (2014-2019)

5 North America
5.1 North America Hemoglobinopathy Drugs Market Size (2014-2019)
5.2 Hemoglobinopathy Drugs Key Players in North America
5.3 North America Hemoglobinopathy Drugs Market Size by Type
5.4 North America Hemoglobinopathy Drugs Market Size by Application

6 Europe
6.1 Europe Hemoglobinopathy Drugs Market Size (2014-2019)
6.2 Hemoglobinopathy Drugs Key Players in Europe
6.3 Europe Hemoglobinopathy Drugs Market Size by Type
6.4 Europe Hemoglobinopathy Drugs Market Size by Application

7 China
7.1 China Hemoglobinopathy Drugs Market Size (2014-2019)
7.2 Hemoglobinopathy Drugs Key Players in China
7.3 China Hemoglobinopathy Drugs Market Size by Type
7.4 China Hemoglobinopathy Drugs Market Size by Application

8 Japan
8.1 Japan Hemoglobinopathy Drugs Market Size (2014-2019)
8.2 Hemoglobinopathy Drugs Key Players in Japan
8.3 Japan Hemoglobinopathy Drugs Market Size by Type
8.4 Japan Hemoglobinopathy Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hemoglobinopathy Drugs Market Size (2014-2019)
9.2 Hemoglobinopathy Drugs Key Players in Southeast Asia
9.3 Southeast Asia Hemoglobinopathy Drugs Market Size by Type
9.4 Southeast Asia Hemoglobinopathy Drugs Market Size by Application

10 India
10.1 India Hemoglobinopathy Drugs Market Size (2014-2019)
10.2 Hemoglobinopathy Drugs Key Players in India
10.3 India Hemoglobinopathy Drugs Market Size by Type
10.4 India Hemoglobinopathy Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Hemoglobinopathy Drugs Market Size (2014-2019)
11.2 Hemoglobinopathy Drugs Key Players in Central & South America
11.3 Central & South America Hemoglobinopathy Drugs Market Size by Type
11.4 Central & South America Hemoglobinopathy Drugs Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hemoglobinopathy Drugs Introduction
12.1.4 Novartis Revenue in Hemoglobinopathy Drugs Business (2014-2019))
12.1.5 Novartis Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hemoglobinopathy Drugs Introduction
12.2.4 AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Bluebird
12.3.1 Bluebird Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hemoglobinopathy Drugs Introduction
12.3.4 Bluebird Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.3.5 Bluebird Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hemoglobinopathy Drugs Introduction
12.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Emmaus Medical
12.5.1 Emmaus Medical Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hemoglobinopathy Drugs Introduction
12.5.4 Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.5.5 Emmaus Medical Recent Development
12.6 Acceleron Pharma
12.6.1 Acceleron Pharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hemoglobinopathy Drugs Introduction
12.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.6.5 Acceleron Pharma Recent Development
12.7 HemaQuest Pharmaceuticals
12.7.1 HemaQuest Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hemoglobinopathy Drugs Introduction
12.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.7.5 HemaQuest Pharmaceuticals Recent Development
12.8 Eli Lilly and Company
12.8.1 Eli Lilly and Company Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hemoglobinopathy Drugs Introduction
12.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.8.5 Eli Lilly and Company Recent Development
12.9 Celgene
12.9.1 Celgene Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hemoglobinopathy Drugs Introduction
12.9.4 Celgene Revenue in Hemoglobinopathy Drugs Business (2014-2019)
12.9.5 Celgene Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Table
List of Tables and Figures

Table Hemoglobinopathy Drugs Key Market Segments
Table Key Players Hemoglobinopathy Drugs Covered
Table Global Hemoglobinopathy Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Hydroxyurea Figures
Table Key Players of Hydroxyurea
Figuer Glutamine Figures
Table Key Players of Glutamine
Figuer Zynteglo Figures
Table Key Players of Zynteglo
Figuer Other Figures
Table Key Players of Other
Table Global Hemoglobinopathy Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Hemoglobinopathy Drugs Market Share by Application in 2018 & 2025
Figure Sickle Cell Diseases Case Studies
Figure Thalassemia Case Studies
Figure Hemoglobinopathy Drugs Report Years Considered
Figure Global Hemoglobinopathy Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hemoglobinopathy Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Hemoglobinopathy Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Hemoglobinopathy Drugs Market Share by Regions 2014-2019
Figure Global Hemoglobinopathy Drugs Market Share by Regions 2014-2019
Figure Global Hemoglobinopathy Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Hemoglobinopathy Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Hemoglobinopathy Drugs Market Share by by Players (2014-2019)
Figure Global Hemoglobinopathy Drugs Market Share by by Players in 2018
Table Global Hemoglobinopathy Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hemoglobinopathy Drugs Product/Solution/Service
Table Date of Enter into Hemoglobinopathy Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hemoglobinopathy Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Hemoglobinopathy Drugs Market Size Share by Type (2014-2019)
Figure Global Hemoglobinopathy Drugs Market Size Market Share by Type (2014-2019)
Table Global Hemoglobinopathy Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Hemoglobinopathy Drugs Market Size Share by Application (2014-2019)
Figure Global Hemoglobinopathy Drugs Market Size Market Share by Application (2014-2019)
Figure Global Hemoglobinopathy Drugs Revenue Market Share by Application in 2018
Figure North America Hemoglobinopathy Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Hemoglobinopathy Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Hemoglobinopathy Drugs Market Share (2018-2019)
Table North America Hemoglobinopathy Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Hemoglobinopathy Drugs Market Share by Type 2014-2019
Table North America Hemoglobinopathy Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Hemoglobinopathy Drugs Market Share by Application 2014-2019
Figure Europe Hemoglobinopathy Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Hemoglobinopathy Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Hemoglobinopathy Drugs Market Share (2018-2019)
Table Europe Hemoglobinopathy Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Hemoglobinopathy Drugs Market Share by Type 2014-2019
Table Europe Hemoglobinopathy Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Hemoglobinopathy Drugs Market Share by Application 2014-2019
Figure China Hemoglobinopathy Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Hemoglobinopathy Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Hemoglobinopathy Drugs Market Share (2018-2019)
Table China Hemoglobinopathy Drugs Market Size by Type 2014-2019 (Million US$)
Table China Hemoglobinopathy Drugs Market Share by Type 2014-2019
Table China Hemoglobinopathy Drugs Market Size by Application 2014-2019 (Million US$)
Table China Hemoglobinopathy Drugs Market Share by Application 2014-2019
Figure Japan Hemoglobinopathy Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Hemoglobinopathy Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Hemoglobinopathy Drugs Market Share (2018-2019)
Table Japan Hemoglobinopathy Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Hemoglobinopathy Drugs Market Share by Type 2014-2019
Table Japan Hemoglobinopathy Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Hemoglobinopathy Drugs Market Share by Application 2014-2019
Figure Southeast Asia Hemoglobinopathy Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hemoglobinopathy Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hemoglobinopathy Drugs Market Share (2018-2019)
Table Southeast Asia Hemoglobinopathy Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Hemoglobinopathy Drugs Market Share by Type 2014-2019
Table Southeast Asia Hemoglobinopathy Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Hemoglobinopathy Drugs Market Share by Application 2014-2019
Figure India Hemoglobinopathy Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Hemoglobinopathy Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Hemoglobinopathy Drugs Market Share (2018-2019)
Table India Hemoglobinopathy Drugs Market Size by Type 2014-2019 (Million US$)
Table India Hemoglobinopathy Drugs Market Share by Type 2014-2019
Table India Hemoglobinopathy Drugs Market Size by Application 2014-2019 (Million US$)
Table India Hemoglobinopathy Drugs Market Share by Application 2014-2019
Figure Central & South America Hemoglobinopathy Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hemoglobinopathy Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hemoglobinopathy Drugs Market Share (2018-2019)
Table Central & South America Hemoglobinopathy Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Hemoglobinopathy Drugs Market Share by Type 2014-2019
Table Central & South America Hemoglobinopathy Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Hemoglobinopathy Drugs Market Share by Application 2014-2019
Table Novartis Company Details
Table Novartis Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table Novartis Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Bluebird Company Details
Table Bluebird Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure Bluebird Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table Bluebird Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Emmaus Medical Company Details
Table Emmaus Medical Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table Emmaus Medical Recent Development
Table Acceleron Pharma Company Details
Table Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table Acceleron Pharma Recent Development
Table HemaQuest Pharmaceuticals Company Details
Table HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table HemaQuest Pharmaceuticals Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Celgene Company Details
Table Celgene Revenue in Hemoglobinopathy Drugs Business 2014-2019 (Million US$)
Figure Celgene Revenue Growth Rate in Hemoglobinopathy Drugs Business (2014-2019)
Table Celgene Recent Development
Table Global Hemoglobinopathy Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Hemoglobinopathy Drugs Market Size Share by Regions (2019-2025)
Figure Global Hemoglobinopathy Drugs Market Size Share by Regions in 2025
Figure North America Hemoglobinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hemoglobinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Hemoglobinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hemoglobinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hemoglobinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Hemoglobinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hemoglobinopathy Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Hemoglobinopathy Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Hemoglobinopathy Drugs Market Size by Product (2019-2025)
Figure Global Hemoglobinopathy Drugs Market Size by Product in 2025
Table Global Hemoglobinopathy Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Hemoglobinopathy Drugs Market Size by Application (2019-2025)
Figure Global Hemoglobinopathy Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us